THE EFFECT OF ETRASIMOD ON FECAL CALPROTECTIN AND HIGHSENSITIVITY C-REACTIVE PROTEIN: RESULTS FROM THE ELEVATE UC CLINICAL PROGRAM

被引:0
|
作者
Jairath, Vipul
Rubin, David T.
Verstockt, Bram
Cekin, Ayhan Hilmi
Abreu, Maria T.
Lees, Charlie W.
Fellmann, Marc
Woolcott, John
Crosby, Catherine
Wu, Joseph
Bhattacharjee, Abhishek
Herman, David
Gu, Guibao
Siegmund, Britta
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1793
引用
收藏
页码:S816 / S816
页数:1
相关论文
共 50 条
  • [41] Novel biomarkers of ulcerative colitis activity: A comparison of urinary PGE-M, fecal calprotectin and C-reactive protein (CRP) levels
    Schwartz, David
    Maltz, Brad
    Slaughter, Christopher
    Milne, Ginger L.
    Sanchez, Stephanie C.
    Morrow, Jason
    Parikh, Alexander A.
    Merchant, Nipun
    GASTROENTEROLOGY, 2008, 134 (04) : A643 - A643
  • [42] Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn's disease
    Hoog, Charlotte M.
    Bark, Lars-Ake
    Brostrom, Olle
    Sjoqvist, Urban
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (09) : 1084 - 1090
  • [43] Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small-bowel Crohn's disease
    Egea Valenzuela, Juan
    Pereniguez Lopez, Ana
    Perez Fernandez, Virginia
    de las Parras, Fernando Alberca
    Carballo Alvarez, Fernando
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (07) : 394 - 400
  • [44] C-reactive protein and atherogenesis: From fatty streak to clinical event
    Bisoendial, Radjesh J.
    Kastelein, John J. P.
    Stroes, Erik S. G.
    ATHEROSCLEROSIS, 2007, 195 (02) : E10 - E18
  • [45] Effect of alcohol intake on C-reactive protein: Consistent results from three different geograhpical areas
    Imhof, A
    Froehlich, M
    Doering, A
    Thorand, B
    Amouyel, P
    Helbecque, N
    Lowe, G
    Rumley, A
    Koenig, W
    CIRCULATION, 2001, 104 (17) : 805 - 805
  • [46] Effect of alcohol intake on C-reactive protein: Consistent Results from three different geographical areas
    Imhof, A
    Froehlich, M
    Thorand, B
    Amouyel, P
    Helbecque, N
    Lowe, GDO
    Rumley, A
    Koenig, W
    EUROPEAN HEART JOURNAL, 2002, 23 : 321 - 321
  • [47] A single measurement of fecal calprotectin, particularly if combined with hemoglobin and C-reactive protein levels, predicts Crohn's disease prognosis - a prospective study
    Magro, F.
    Estevinho, M. M.
    Catalano, G.
    Patita, M.
    Arroja, B.
    Lago, P.
    Rosa, I.
    Tavares-de-Sousa, H.
    Ministro, P.
    Roseira, J.
    Cancela, E.
    Sousa, P.
    Portela, F.
    Correia, L.
    Moreira, P.
    Santiago, M.
    Dias, S.
    Afonso, J.
    Danese, S.
    Peyrin-Biroulet, L.
    Dias, C. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 863 - 863
  • [48] Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease
    Verdejo, Cristina
    Hervias, Daniel
    Roncero, Oscar
    Arias, Angel
    Bouhmidi, Abdelmouneim
    Lorente, Rufo
    Saluena, Irina
    Lucendo, Alfredo J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (12) : 1521 - 1527
  • [49] Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn's Disease in Children
    Akutko, Katarzyna
    Iwanczak, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [50] Fecal Calprotectin, Serum Ferritin, and C-Reactive Protein Levels in Individuals with Inflammatory Bowel Disease Concomitant with Type 2 Diabetes: A Retrospective Study
    Sargautiene, Vanda
    Gavars, Didzis
    Ligere, Renate
    CLINICAL DIABETOLOGY, 2024, 13 (02): : 106 - 115